Clinical Social Workers in Trussville, AL Accepting Medicare

5 Clinical Social Workers found. Showing 1 - 5

Jessica Leigh Coleman, LICSW, PIP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8125 Caldwell Dr, Trussville, AL 35173 Phone: 205-601-8983

Jennifer Lucy Otwell, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 114 Maple Ave, Trussville, AL 35173 Phone: 205-283-7112

Mr. Jermaine A Wall, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 459 Main St # 357, Trussville, AL 35173 Phone: 205-418-8223    Fax: 205-708-0094

Mrs. Sarah Robertson Pendleton, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 248 Glen Cross Dr, Trussville, AL 35173 Phone: 205-246-9915

Adrienne Kelley Cato, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 229 Snake Hill Rd, Trussville, AL 35173 Phone: 205-601-9029

News Archive

Etch recipe allows engineers and product developers to design diamond devices

Advanced Diamond Technologies (ADT) is making broadly available an etch recipe which enables engineers and product developers to reliably and affordably design micro devices and sensors out of diamond.

First cryoablation procedure using new mapping catheter performed at Baylor Heart and Vascular Hospital

Baylor Jack and Jane Hamilton Heart and Vascular Hospital today announced the first patient procedure in the U.S. using the Achieve Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.

The 'chicken-and-egg' problem with diabetes and depression

Researchers have long known that type-2 diabetes and depression often go hand in hand. However, it's been unclear which condition develops first in patients who end up with both. Now, a new study led by Johns Hopkins doctors suggests that this chicken-and-egg problem has a dual answer: Patients with depression have an increased risk of developing type-2 diabetes, and patients with type-2 diabetes have an increased risk of developing depression.

Genentech announces positive results from Phase II study of T-DM1

Genentech, Inc., a wholly owned member of the Roche Group, today announced positive results from a Phase II study of trastuzumab-DM1 (T-DM1). As assessed by independent review, T-DM1 shrank the tumors (also known as objective response) in 33 percent of women with advanced (metastatic) HER2-positive breast cancer that had worsened following previous treatment.

Read more Medical News

› Verified 5 days ago